Stock A096530 SEEGENE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Seegene, Inc.

Equities

A096530

KR7096530001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
22,200 KRW +0.45% Intraday chart for Seegene, Inc. +5.71% -3.06%
Mar. 14 Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 24 Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Seegene and UK Health Security Agency convene a summit to collectively realize 'a World Free from All Diseases'
AQ
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"
AQ
Seegene and Springer Nature Announce Awardees for the Open Innovation Program
AQ
Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'
AQ
Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases
CI
Seegene obtains ISO45001 certification
AQ
Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy; Expanded Collaboration Aims To Improve Syndromic Infectious Disease Testing
MT
Microbix Brief: Microbix and Seegene USA Jointly Enhancing Lab Test Accuracy
MT
Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability
AQ
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on July 13, 2023.
CI
Seegene Unveils 'Open Innovation Program Powered by Seegene' in Partnership with Springer Nature
AQ
Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on February 28, 2023.
CI
Seegene, Inc.'s Equity Buyback announced on February 28, 2023, has expired with 2,046,354 shares, representing 4.11% for KRW 49,998.4 million.
CI
Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Seegene Inc. Unveils Solutions to Popularize Molecular Diagnostics At 2023 AACC
CI
Seegene, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.
CI
Seegene, Inc. authorizes a Buyback Plan.
CI
Seegene, Inc. and Werfen Partner to Collaborate on Onesystem Business to Develop Syndromic qPCR Assays
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A096530 Stock
  4. News Seegene, Inc.